Mechanisms of action: two distinct cascades BPC-157: NO pathway modulation and growth factor expression Preclinical studies have suggested that BPC-157 acts primarily through three axes: NO (nitric oxide) pathway : BPC-157 modulates endothelial NO signaling, favoring local vasodilation and perfusion of injured tissues VEGF-R2 expression and angiogenesis : animal models have shown increased formation of new capillaries at the injury site Interactions with dopaminergic, serotonergic and GABAergic pathways : BPC-157 exhibits a pleiotropic profile influencing neurological and digestive healing Documented strengths (animal models): healing of tendons, ligaments, gastrointestinal mucosa, bone, teeth, vessels, cornea
c-Jun, krox-20, and integrin 4 expression following chronic nerve compression injury
Buford of Texas Orthobiologics is the expert in regenerative medicine in the Dallas/Fort Worth area
BPC-157 resistance to gastric degradation is unusual and has prompted research into oral administration models
Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application
Enhances brain health by supporting memory, focus, and cognitive performance